Eli Lilly sued for age discrimination by U.S. agency EEOC
Please try another search
Stock Markets 3 hours ago (Sep 26, 2022 08:31PM ET)
© Reuters. FILE PHOTO: FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar/File Photo
By Jonathan Stempel
(Reuters) – Eli Lilly (NYSE:) and Co was sued on Monday by the U.S. Equal Employment Opportunity Commission, which accused the drugmaker of illegally refusing to hire older workers for sales representative jobs because of their age. The complaint said Lilly’s violations began after Stephen Fry, its senior vice president for human resources and diversity, lamented during an April 2017 “Leadership Town Hall” that its sales force was skewed toward older workers, with 20% fewer “millennials” than the American workforce.
According to the EEOC, Fry suggested that the lack of millennials was a problem, and the Indianapolis-based company would target 40% “Early Career” hiring.
Managers then changed their hiring practices for sales representatives, sometimes requiring greater review and approval before extending offers to older candidates, even after some recognized that the 40% goal was illegal, the EEOC said. The target remained through 2021, it added.
Lilly, in a statement, denied the accusations and said it was “committed to fostering and promoting a culture of diversity and respect.”
The lawsuit filed in Indianapolis federal court accused Lilly of violating the federal Age Discrimination in Employment Act.
It seeks to permanently enjoin future discrimination, obtain back pay and other damages for people not hired because of their age, and improve training for supervisors and managers.
“This case underscores the continued need for the EEOC to break down barriers to employment” for older Americans as they work longer and in larger numbers, Robert Weisberg, an EEOC lawyer who helped bring the case, said in a statement.
Lilly’s top-selling product is Trulicity, a treatment for type 2 diabetes.
On Aug. 11, Lilly said Fry would retire at the end of 2022 after more than 35 years at the company.
The case is EEOC v Lilly USA LLC, U.S. District Court, Southern District of Indiana, No. 22-01882.
Related Articles
U.S. to appeal court loss against sugar merger By Reuters – Sep 26, 2022 1
WASHINGTON (Reuters) -The U.S. Justice Department said on Monday it would appeal a judge’s ruling that U.S. Sugar Corp’s plans to buy rival Imperial Sugar Co was legal under…
Grab expects to break-even on adjusted EBIDTA by H2 2024 – CFO By Reuters – Sep 26, 2022 4
By Chen Lin, Anshuman Daga and Xinghui Kok SINGAPORE (Reuters) -Grab Holdings Ltd, Southeast Asia’s biggest ride-hailing and food delivery firm, expects to break even on its…
Optus, Australian govt clash over cyber attack amid reports of hacker retreat By Reuters – Sep 26, 2022 1
SYDNEY (Reuters) – Australia’s No. 2 telecoms firm Optus, hit by a massive cyber attack, faced a barrage of criticism on Tuesday, with the government accusing it of trying to…
Responses